NSCLC cells are capable of restraining the proliferation and immune function of TILs by releasing a variety of immunosuppressive factors, such as transforming growth factor beta 1(TGF-β 1) (31). The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.